# Lexeo Therapeutics, Inc.: Form 8-K, filed Mar 11, 2024

- Company: [Lexeo Therapeutics, Inc.](/companies/lxeo.md) (CIK 1907108)
- Form: 8-K
- Filed: 2024-03-11
- Accepted by EDGAR: Mar 11, 2024, 16:11 ET
- Period: 2024-03-11
- Accession: 0000950170-24-029249
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1907108/000095017024029249/lxeo-20240311.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1907108/000095017024029249/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1907108/000095017024029249/lxeo-20240311.htm

Filed Mar 11, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-029249. Last ingested by Listed: Nov 14, 2026, 19:59 ET. No prices; not investment advice.
